KR920018011A - N-아실-α-아미노산 유도체 - Google Patents

N-아실-α-아미노산 유도체 Download PDF

Info

Publication number
KR920018011A
KR920018011A KR1019920004818A KR920004818A KR920018011A KR 920018011 A KR920018011 A KR 920018011A KR 1019920004818 A KR1019920004818 A KR 1019920004818A KR 920004818 A KR920004818 A KR 920004818A KR 920018011 A KR920018011 A KR 920018011A
Authority
KR
South Korea
Prior art keywords
group
hydrogen
general formula
amidino
guanidino
Prior art date
Application number
KR1019920004818A
Other languages
English (en)
Other versions
KR100254757B1 (ko
Inventor
알리흐 레오
하드바리 파울
휠 젤러 마리안느
뮐러 마르셀
스타이너 베아트
벨러 토마스
Original Assignee
프리돌린 클라우스너, 롤란드 보러
에프, 호프만-라 롯슈 아크티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 프리돌린 클라우스너, 롤란드 보러, 에프, 호프만-라 롯슈 아크티엔게젤샤프트 filed Critical 프리돌린 클라우스너, 롤란드 보러
Publication of KR920018011A publication Critical patent/KR920018011A/ko
Application granted granted Critical
Publication of KR100254757B1 publication Critical patent/KR100254757B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Gas Burners (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

내용 없음

Description

N-아실-α-아미노산 유도체
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (3)

  1. 하기 일반식(Ⅰ)의 N-아로일-α-아미노카복실산 유도체 및 그의 수화물 또는 용매화물 및 그의 생리학적으로 이용가능한 염 :
    상기식에서, L은 일반식
    의 그룹이고, 이때, R은 아미디노 또는 구아니디노이고, X 및 Y중의 하나는 CH이고, 다른 하나는 CH 또는 N이고, R0는 수소 또는 아미디노이고, t는 2 내지 6의 정수이고, R′ ,R" 및 R"'는 수소 또는 α-아미노카복실산에 통상적인 N-치환체 또는 측쇄이고, 상기에 의해서 R′ ,R" 및 R"'에 존재하는 하이드록시 또는 카복시 그룹이 에테르화되거나, 또는 각각 에스테르화 또는 아미드화될수 있고, R′,R" 및 R"'에 존재하는 아미노 그룹은 C1-6-알카노일화 또는 알로일화될 수 있고, Q는 일반식
    -N(V′)(CH2)V-C(V",V"')CH2OCH2COO-T Q8
    의 그룹이거나, 또는 R′및 R"가 이들이 결합된 N원자 및 C원자와 함께 고리를 형성할 때 또한 일반식
    의 그룹일 수 있고, 이때 n은 0 또는 1이고, v는 0 내지 3의 정수이고, T 및 T′는 수소 또는 생리학적 조건하에서 절단될 수 있는 저릅알킬 또는 페닐저급알킬 그룹이고, V 내지 V"'는 수소 또는 저급알킬이고, U 및 U′는 수소, C1-6- 알카노일 또는 아로일이고, Ar은 아릴이고, R2내지 R5는 수소, 저급알킬, 저급알콕시, 할로겐 또는 -OCH2COO-T′그룹이거나 또는 R2및 R3는 이들이 결합된 페닐 그룹과 함께 1-나프틸 그룹을 형성한다.
  2. 하기 일반식(Ⅱ) 또는 (Ⅲ)의 화합물 :
    상기식들에서, L0는 일반식
    R1-(CH2)t또는 L2
    이고, 이때 A는 임의로 보호된 아미디노 또는 구아니디노 그룹이고, R1은 임의로 보호된 아미노 또는 구아니디노 그룹이고, E′, E", E"' 및 G는 각각 일반식(Ⅰ)에서의 R′, R", R"' 및 Q와 동일한 의미를 가지나, 단 R1이 아미노 또는 구아니디오이거나, 또는 A가 아미디노 또는 구아니디노인 경우에, E′, E", E"' 및 G중 적어도 하나는 적어도 하나의 카복실산 에스테르 그룹 및/또는 에테르그룹 및/또는 보호된 아미노 그룹을 함유한다.
  3. 활성 성분으로서 제1항에 따른 화합물을 함유하는, 특히 혈소판에 대한 결합 단백질의 결합, 및 혈소판 응집 및 세포-세포 결합에 의해 야기된 질병의 치료 또는 예방을 위한 약학 제제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019920004818A 1991-03-26 1992-03-25 N-아실-알파-아미노산 유도체 KR100254757B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CH910/91-9 1991-03-26
CH00910/91-9 1991-03-26
CH91091 1991-03-26
CH176/92 1992-01-22
CH17692 1992-01-22

Publications (2)

Publication Number Publication Date
KR920018011A true KR920018011A (ko) 1992-10-21
KR100254757B1 KR100254757B1 (ko) 2000-05-01

Family

ID=25683769

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920004818A KR100254757B1 (ko) 1991-03-26 1992-03-25 N-아실-알파-아미노산 유도체

Country Status (29)

Country Link
US (4) US5378712A (ko)
EP (1) EP0505868B1 (ko)
JP (1) JPH06102640B2 (ko)
KR (1) KR100254757B1 (ko)
AT (1) ATE127800T1 (ko)
AU (1) AU659629B2 (ko)
BG (1) BG60796B2 (ko)
CA (1) CA2061661A1 (ko)
CZ (1) CZ283508B6 (ko)
DE (1) DE59203619D1 (ko)
DK (1) DK0505868T3 (ko)
DZ (1) DZ1566A1 (ko)
EE (1) EE02982B1 (ko)
ES (1) ES2078570T3 (ko)
FI (1) FI105024B (ko)
GR (1) GR3018374T3 (ko)
HK (1) HK1003997A1 (ko)
HU (2) HU222498B1 (ko)
IE (1) IE70601B1 (ko)
IL (1) IL101311A (ko)
IS (1) IS3825A (ko)
MY (1) MY108441A (ko)
NO (1) NO178227C (ko)
NZ (1) NZ242067A (ko)
RO (1) RO109193B1 (ko)
RU (1) RU2097378C1 (ko)
SK (1) SK279688B6 (ko)
TW (1) TW198011B (ko)
UA (1) UA39849C2 (ko)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
DE4127404A1 (de) 1991-08-19 1993-02-25 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
JPH08505391A (ja) * 1992-12-30 1996-06-11 スミスクライン・ビーチャム・コーポレイション 化合物
US5750754A (en) * 1993-03-29 1998-05-12 Zeneca Limited Heterocyclic compounds
US5753659A (en) * 1993-03-29 1998-05-19 Zeneca Limited Heterocyclic compouds
EP0825184B1 (en) * 1993-03-29 2001-06-20 AstraZeneca AB Heterocyclic derivatives as platelet aggregation inhibitors
NZ262942A (en) * 1993-03-29 1997-07-27 Zeneca Ltd Pyridyl substituted piperazine and various other derivatives of azaheteroaryl substituted piperazines; pharmaceutical compositions
US5652242A (en) * 1993-03-29 1997-07-29 Zeneca Limited Heterocyclic derivatives
HUT70045A (en) * 1993-06-17 1995-09-28 Takeda Chemical Industries Ltd 2-piperazinone derivatives parmaceutical compositions containing them and process for producing them
US5463011A (en) * 1993-06-28 1995-10-31 Zeneca Limited Acid derivatives
GB9313268D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Chemical compounds
GB9313285D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Acid derivatives
EP0706999A1 (en) * 1993-06-30 1996-04-17 Sumitomo Pharmaceuticals Company, Limited Novel dipiperidine derivative
US5523302A (en) * 1993-11-24 1996-06-04 The Du Pont Merck Pharmaceutical Company Aromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonists
US5446056A (en) * 1993-11-24 1995-08-29 The Du Pont Merck Pharmaceutical Company Isoxazoline compounds useful as fibrinogen receptor antagonists
US5849736A (en) * 1993-11-24 1998-12-15 The Dupont Merck Pharmaceutical Company Isoxazoline and isoxazole fibrinogen receptor antagonists
PT656348E (pt) * 1993-12-03 2000-10-31 Hoffmann La Roche Derivados do acido acetico como medicamentos
US5563158A (en) * 1993-12-28 1996-10-08 The Dupont Merck Pharmaceutical Company Aromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonists
CA2216162A1 (en) * 1995-04-26 1996-10-31 Takeda Chemical Industries, Ltd. Piperazinones useful as inhibitors of platelet aggregation
ZA963391B (en) * 1995-05-24 1997-10-29 Du Pont Merck Pharma Isoxazoline fibrinogen receptor antagonists.
NZ315677A (en) * 1995-09-07 2000-02-28 F 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency
DE10006453A1 (de) * 2000-02-14 2001-08-16 Bayer Ag Piperidylcarbonsäuren als Integrinantagonisten
US7163918B2 (en) * 2000-08-22 2007-01-16 New River Pharmaceuticals Inc. Iodothyronine compositions
US8394813B2 (en) 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
US20060014697A1 (en) * 2001-08-22 2006-01-19 Travis Mickle Pharmaceutical compositions for prevention of overdose or abuse
EP1677783A2 (en) 2003-10-08 2006-07-12 Nicholas Piramal India Limited Fibrinogen receptor antagonists and their use
FR3027518B1 (fr) 2014-10-24 2018-01-19 Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic Utilisation d'ester d'isosorbide et de derives n-acyles d'acides amines comme agent antivieillissement de la peau humaine
FR3027599A1 (fr) 2014-10-27 2016-04-29 Soc D'exploitation De Produits Pour Les Ind Chimiques Seppic Utilisation d'ester de derives n-acyles d'acide amines et de polyols comme agent antivieillissement de la peau humaine
CN105348147A (zh) * 2015-10-08 2016-02-24 上海吉尔多肽有限公司 一种Nα-芴甲氧羰基-Nγ-叔丁氧羰基-L-2,4-二氨基丁酸的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2518088B1 (fr) * 1981-12-16 1987-11-27 Roques Bernard Nouveaux derives d'aminoacides, et leur application therapeutique
CA1261335A (en) * 1984-08-29 1989-09-26 Hoffmann-La Roche Limited/Hoffmann-La Roche Limitee Ethylenediamine monoamide derivatives
US5256645A (en) * 1988-03-04 1993-10-26 Hoffmann-La Roche Inc. Amino acid derivatives
CA1328333C (en) * 1988-03-04 1994-04-05 Quirico Branca Amino acid derivatives
US5039805A (en) * 1988-12-08 1991-08-13 Hoffmann-La Roche Inc. Novel benzoic and phenylacetic acid derivatives
US5084466A (en) * 1989-01-31 1992-01-28 Hoffmann-La Roche Inc. Novel carboxamide pyridine compounds which have useful pharmaceutical utility
CA2037153A1 (en) * 1990-03-09 1991-09-10 Leo Alig Acetic acid derivatives

Also Published As

Publication number Publication date
EP0505868B1 (de) 1995-09-13
HU222498B1 (hu) 2003-07-28
ES2078570T3 (es) 1995-12-16
CZ283508B6 (cs) 1998-04-15
HUT66455A (en) 1994-11-28
DE59203619D1 (de) 1995-10-19
DZ1566A1 (fr) 2002-02-17
NO921169D0 (no) 1992-03-25
RO109193B1 (ro) 1994-12-30
BG60796B2 (bg) 1996-03-29
EP0505868A3 (en) 1993-05-05
HU211978A9 (en) 1996-01-29
JPH05148204A (ja) 1993-06-15
GR3018374T3 (en) 1996-03-31
TW198011B (ko) 1993-01-11
RU2097378C1 (ru) 1997-11-27
EP0505868A2 (de) 1992-09-30
CA2061661A1 (en) 1992-09-27
AU1308192A (en) 1992-10-01
US5658928A (en) 1997-08-19
UA39849C2 (uk) 2001-07-16
NO178227B (no) 1995-11-06
NO921169L (no) 1992-09-28
US5670515A (en) 1997-09-23
KR100254757B1 (ko) 2000-05-01
FI921163A (fi) 1992-09-27
IL101311A0 (en) 1992-11-15
JPH06102640B2 (ja) 1994-12-14
ATE127800T1 (de) 1995-09-15
IL101311A (en) 2000-07-16
MY108441A (en) 1996-09-30
NO178227C (no) 1996-02-14
DK0505868T3 (da) 1995-12-27
US5747522A (en) 1998-05-05
AU659629B2 (en) 1995-05-25
CS89392A3 (en) 1992-10-14
EE02982B1 (et) 1997-04-15
FI105024B (fi) 2000-05-31
SK279688B6 (sk) 1999-02-11
IE70601B1 (en) 1996-12-11
IE920953A1 (en) 1992-10-07
HU9200899D0 (en) 1992-05-28
US5378712A (en) 1995-01-03
IS3825A (is) 1992-09-27
HK1003997A1 (en) 1998-11-13
NZ242067A (en) 1995-02-24
FI921163A0 (fi) 1992-03-18

Similar Documents

Publication Publication Date Title
KR920018011A (ko) N-아실-α-아미노산 유도체
ES2094350T3 (es) Cromano y tiocromanos con sustituyentes de feniletinilo en la posicion 7 que tienen actividad biologica de tipo retinoide.
CA2102454A1 (fr) Derives de l&#39;erythromycine, leur procede de preparation, leur application comme medicaments
HK57197A (en) Naphthalene derivatives procedure for their preparation and pharmaceutical compositions containing them
KR900006318A (ko) 피페리디닐 벤즈이미다졸
AU557691B2 (en) 2-penem antibiotics and their oxa-aza-, and carba analogues
EP0527687A3 (fr) Nouveaux dérivés d&#39;aryléthylamines, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
KR950017928A (ko) 아세트산 유도체
KR900016098A (ko) 카페인산의 유도체 및 이를 함유하는 약제학적 조성물
SE7906472L (sv) Nya 3-(aminoetyl)-fenol-derivat och salter derav, sett for framstellning och anvendning derav sasom lekemedel samt farmaceutiska kompositioner innehallande dessa foreningar
ES2121892T3 (es) Ciclopentano- y ciclopenteno-beta-aminoacidos.
KR950017943A (ko) 아미디노페닐알라닌 유도체, 이의 제조방법, 이의 용도 및 이를 함유하는 항응고제로서의 조성물
IL48453A (en) Substituted 6-oxa-1-azatricyclo-(6.2.2.0 )dodecan-5-ones and 1,4-ethano-5-oxo octa (or decahydro)quinoline,their preparation and pharmaceutical compositions containing them
DE3870167D1 (de) N-(vinblastinoyl-23)-derivate von 1-aminomethylposphonsaeure, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
CA2273985A1 (fr) Nouveaux derives de l&#39;erythromycine, leur procede de preparation et leur application comme medicaments
ATE69611T1 (de) Piperazinylalkylpiperazindion-derivate, ihre verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen.
IL102541A0 (en) Pharmaceutical antihypertensive combination preparations
AU7532787A (en) New derivatives of 2,6-piperazinedione, their preparation process and the pharmaceutical compositions containing them
ATE18993T1 (de) Dibenzocycloheptenyliden-verbindungen zur verwendung bei der modulation der immunreaktion.
FR2674436B1 (fr) Nouvelle utilisation de sterouides 4,9,11-trieniques dans des compositions destinees a l&#39;administration chez la dinde.
FI891033A (fi) Lim.
KR920700210A (ko) 신규 이미다졸 유도체, 그의 제법 및 그의 의약용도
DE69011235D1 (de) Derivate von N-(Vincristinyl-23) und N-(Noranhydro-5-vinblastinyl-23) von Amino-1-methylphosphonsäure, ihre Verfahren zur Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
KR890701572A (ko) 고리형 아미노산의 유도체,이들의 염, 이들을 함유하는 약제조성물 및 이들의 제조방법.
IL62308A (en) 1-(alkanoylamino-phenoxy)-3-alkynylamino-propan-2-ols,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20050107

Year of fee payment: 6

LAPS Lapse due to unpaid annual fee